# Adaptimmune Therapeutics PLC: Form 8-K, filed Jul 28, 2025

- Company: [Adaptimmune Therapeutics PLC](/companies/adapy.md) (CIK 1621227)
- Form: 8-K
- Filed: 2025-07-28
- Accepted by EDGAR: Jul 28, 2025, 07:37 ET
- Period: 2025-07-27
- Accession: 0001104659-25-071009
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1621227/000110465925071009/tm2521829d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1621227/000110465925071009/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.05: Exit or disposal costs
- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1621227/000110465925071009/tm2521829d1_8k.htm

Filed Jul 28, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-071009. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.